Lindbrook Capital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,278
| Closed | -$5.21K | – | 2904 |
|
|
2023
Q1 | $5.21K | Buy |
1,278
+231
| +22% | +$942 | ﹤0.01% | 1837 |
|
|
2022
Q4 | $5.26K | Buy |
1,047
+866
| +478% | +$4.35K | ﹤0.01% | 1800 |
|
|
2022
Q3 | $2K | Sell |
181
-42
| -19% | -$464 | ﹤0.01% | 2184 |
|
|
2022
Q2 | $3K | Buy |
223
+88
| +65% | +$1.18K | ﹤0.01% | 1875 |
|
|
2022
Q1 | $2K | Buy |
135
+64
| +90% | +$948 | ﹤0.01% | 2124 |
|
|
2021
Q4 | $1K | Hold |
71
| – | – | ﹤0.01% | 2033 |
|
|
2021
Q3 | $1K | Hold |
71
| – | – | ﹤0.01% | 1818 |
|
|
2021
Q2 | $1K | Hold |
71
| – | – | ﹤0.01% | 1867 |
|
|
2021
Q1 | $2K | Hold |
71
| – | – | ﹤0.01% | 1630 |
|
|
2020
Q4 | $2K | Hold |
71
| – | – | ﹤0.01% | 1535 |
|
|
2020
Q3 | $1K | Hold |
71
| – | – | ﹤0.01% | 1690 |
|
|
2020
Q2 | $1K | Hold |
71
| – | – | ﹤0.01% | 1662 |
|
|
2020
Q1 | $1K | Sell |
71
-1
| -1% | -$14 | ﹤0.01% | 1610 |
|
|
2019
Q4 | $1K | Buy |
+72
| New | +$1K | ﹤0.01% | 1464 |
|